Home
Conditions
Glabellar Frown Lines

Clinical trial condition

Glabellar Frown Lines

Explore clinical trials studying Glabellar Frown Lines. Study availability and eligibility vary by location and protocol.

52 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Glabellar Frown Lines trial results

Recruiting

Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides

NCT06448676

Conditions: Glabellar Frown Lines, Glabellar Furrowing, Wrinkle
Locations: Faceland Amsterdam, Netherlands

Faceland Eindhoven, Netherlands

Faceland Utrecht, Netherlands

View Trial Details

Active, not recruiting

Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines

NCT05766683

Conditions: Glabellar Frown Lines
Locations: Henry Ford Health System Detroit, Michigan, United States

View Trial Details

Completed

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

NCT05481931

Conditions: Glabellar Frown Lines
Locations: Cologne Dermatology Cologne, Germany

View Trial Details

Completed

A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

NCT06585696

Conditions: Glabellar Frown Lines
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines

NCT05148000

Conditions: Canthal Lines, Glabellar Frown Lines
Locations: Galderma Research Site New York, United States

View Trial Details

Completed

AI-09 In Subjects With Glabellar Lines, GL-101

NCT05565950

Conditions: Glabellar Frown Lines
Locations: Eirion Research Site Boca Raton, Florida, United States

Eirion Research Site Miami, Florida, United States

View Trial Details

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)

NCT03985982

Conditions: Glabellar Frown Lines
Locations: Tennessee Clinical Research Center Nashville, Tennessee, United States

View Trial Details

Completed

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

NCT06946160

Conditions: Glabellar Frown Lines, Glabellar Lines
Locations: Center for Research and Training in Skin Diseases And Leprosy Tehran, Tehran Province, Iran

View Trial Details

Completed

Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines

NCT06411002

Conditions: Glabellar Frown Lines
Locations: Revance Nashville, Tennessee, United States

View Trial Details

Completed

Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II

NCT02677805

Conditions: Glabellar Frown Lines
Locations: California Dermatology & Clinical Research Institute Encinitas, California, United States

Center for Clinical and Cosmetic Research Aventura, Florida, United States

Holcomb Kreithen Plastic Surgery Sarasota, Florida, United States

Skin Laser And Surgery Specialists Of New York & New Jersey Hillsborough, New Jersey, United States

View Trial Details

Glabellar Frown Lines

Glabellar Frown Lines trial results

Related conditions